Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 148 No. 2324 (2018)

Clinical characteristics, audiological and neurodevelopmental outcomes of newborns with congenital cytomegalovirus infection: This article was corrected and republished online on April 3, 2019. Please see Erratum (Swiss Med Wkly. 2019;149:w20075)

  • Manuela Kobas
  • Myriam Bickle Graz
  • Anita Carmen Truttmann
  • Eric Giannoni
  • Pascal Meylan
  • Sandra Andrea Asner
DOI
https://doi.org/10.4414/smw.2018.14627
Cite this as:
Swiss Med Wkly. 2018;148:w14627
Published
12.06.2018

Summary

BACKGROUND

Congenital cytomegalovirus (cCMV) infections are the leading nongenetic cause of congenital sensorineural hearing loss (SNHL); however the true impact of cCMV infections remains unknown.

AIMS OF THE STUDY

(1) To identify the number of asymptomatic and symptomatic cCMV infections diagnosed between 1999 and 2014 at the Lausanne University Hospital; (2) to describe the audiological and neurodevelopmental outcomes of infants with cCMV infection; and (3) to compare clinical outcomes between infants born to mothers with primary versus nonprimary infection.

METHODS

This was a single-centre, observational, exploratory, retrospective study of newborns diagnosed with cCMV infection at the Lausanne University Hospital between 1999 and 2014.

RESULTS

Fifty newborns with cCMV infection were identified; 39 (78%) were symptomatic at birth, of whom 29 (74%) were neurologically symptomatic. Twelve children (24%) presented with subsequent abnormal audiological and/or neurodevelopmental outcomes. Newborns born to mothers with a nonprimary infection were more often symptomatic at birth than those born to mothers with a primary infection.

CONCLUSIONS

All infants with subsequent SNHL or abnormal neurodevelopment were symptomatic at birth. Similar long-term neurodevelopmental and audiological outcomes were observed in infants born to mothers with a primary and nonprimary infection.

References

  1. Yamamoto AY, Mussi-Pinhata MM, Isaac M de L, Amaral FR, Carvalheiro CG, Aragon DC, et al. Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J. 2011;30(12):1043–6. doi:.https://doi.org/10.1097/INF.0b013e31822d9640
  2. Schleiss MR. Congenital cytomegalovirus infection: update on management strategies. Curr Treat Options Neurol. 2008;10(3):186–92. doi:.https://doi.org/10.1007/s11940-008-0020-2
  3. Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177–88. doi:.https://doi.org/10.1016/S1473-3099(17)30143-3
  4. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999;104(1):55–60. doi:.https://doi.org/10.1542/peds.104.1.55
  5. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86–102. doi:.https://doi.org/10.1128/CMR.00062-12
  6. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326(10):663–7. doi:.https://doi.org/10.1056/NEJM199203053261003
  7. Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr. 2006;148(3):332–6. doi:.https://doi.org/10.1016/j.jpeds.2005.09.003
  8. Lombardi G, Garofoli F, Stronati M. Congenital cytomegalovirus infection: treatment, sequelae and follow-up. J Matern Fetal Neonatal Med. 2010;23(sup3, Suppl 3):45–8. doi:.https://doi.org/10.3109/14767058.2010.506753
  9. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17(5):355–63. doi:.https://doi.org/10.1002/rmv.544
  10. Karltorp E, Löfkvist U, Lewensohn-Fuchs I, Lindström K, Eriksson Westblad M, Teär Fahnehjelm K, et al. Impaired balance and neurodevelopmental disabilities among children with congenital cytomegalovirus infection. Acta Paediatr. 2014;103(11):1165–73. doi:.https://doi.org/10.1111/apa.12745
  11. Bale JF, Miner L, Petheram SJ. Congenital Cytomegalovirus Infection. Curr Treat Options Neurol. 2002;4(3):225–30. doi:.https://doi.org/10.1007/s11940-002-0039-8
  12. Ross SA, Ahmed A, Palmer AL, Michaels MG, Sánchez PJ, Bernstein DI, et al.; National Institute on Deafness and Other Communication Disorders CHIMES Study. Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J Infect Dis. 2014;210(9):1415–8. doi:.https://doi.org/10.1093/infdis/jiu263
  13. de Vries JJC, Vossen ACTM, Kroes ACM, van der Zeijst BAM. Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers. Rev Med Virol. 2011;21(1):54–61. doi:.https://doi.org/10.1002/rmv.679
  14. Fowler KB, McCollister FP, Sabo DL, Shoup AG, Owen KE, Woodruff JL, et al.; CHIMES Study. A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening. Pediatrics. 2017;139(2):e20162128. doi:.https://doi.org/10.1542/peds.2016-2128
  15. Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57(Suppl 4):S178–81. doi:.https://doi.org/10.1093/cid/cit629
  16. Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372(10):933–43. doi:.https://doi.org/10.1056/NEJMoa1404599
  17. Cevey-Macherel M, Forcada Guex M, Bickle Graz M, Truttmann AC. Neurodevelopment outcome of newborns with cerebral subependymal pseudocysts at 18 and 46 months: a prospective study. Arch Dis Child. 2013;98(7):497–502. doi:.https://doi.org/10.1136/archdischild-2012-303223
  18. Kimberlin DW, Lin C-Y, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143(1):16–25. doi:.https://doi.org/10.1016/S0022-3476(03)00192-6
  19. Amir J, Wolf DG, Levy I. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur J Pediatr. 2010;169(9):1061–7. doi:.https://doi.org/10.1007/s00431-010-1176-9
  20. Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi MM, et al., WAPM Perinatal Infections Working Group. Guidelines on CMV congenital infection. J Perinat Med. 2009;37(5):433–45. doi:.https://doi.org/10.1515/JPM.2009.127
  21. Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 1999;135(1):60–4. doi:.https://doi.org/10.1016/S0022-3476(99)70328-8
  22. Bundesamt für Gesundheit - Swiss Paediatric Surveillance Unit (SPSU) [Internet]. [cited 2016 Apr 29]. Available from: http://www.bag.admin.ch/k_m_meldesystem/00737/index.html?lang=de
  23. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253–76. doi:.https://doi.org/10.1002/rmv.535
  24. Muheim C, Vogel G, Seydoux C, Gillet M, Mosimann F, Von Segesser L, et al. Determinants of protracted cytomegalovirus infection in solid-organ transplant patients. Transplantation. 2002;74(2):226–36. doi:.https://doi.org/10.1097/00007890-200207270-00014
  25. Chatellard P, Sahli R, Iten A, von Overbeck J, Meylan PR. Single tube competitive PCR for quantitation of CMV DNA in the blood of HIV+ and solid organ transplant patients. J Virol Methods. 1998;71(2):137–46. doi:.https://doi.org/10.1016/S0166-0934(97)00087-6
  26. Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW, Jr, Palmer AL, et al.; National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010;303(14):1375–82. doi:.https://doi.org/10.1001/jama.2010.423
  27. Benoist G, Leruez-Ville M, Magny JF, Jacquemard F, Salomon LJ, Ville Y. Management of pregnancies with confirmed cytomegalovirus fetal infection. Fetal Diagn Ther. 2013;33(4):203–14. doi:.https://doi.org/10.1159/000342752
  28. Bodéus M, Beulné D, Goubau P. Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection. Eur J Clin Microbiol Infect Dis. 2001;20(4):248–52. doi:.https://doi.org/10.1007/s100960100484
  29. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis. 1997;175(4):944–6. doi:.https://doi.org/10.1086/513996
  30. Coats DK, Demmler GJ, Paysse EA, Du LT, Libby C. Ophthalmologic findings in children with congenital cytomegalovirus infection. J AAPOS. 2000;4(2):110–6. doi:.https://doi.org/10.1067/mpa.2000.103870
  31. Amir J, Schwarz M, Levy I, Haimi-Cohen Y, Pardo J. Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection? Arch Dis Child. 2011;96(9):846–50. doi:.https://doi.org/10.1136/adc.2010.208405
  32. Fink KR, Thapa MM, Ishak GE, Pruthi S. Neuroimaging of pediatric central nervous system cytomegalovirus infection. Radiographics. 2010;30(7):1779–96. doi:.https://doi.org/10.1148/rg.307105043
  33. Bale JF, Jr. Cytomegalovirus infections. Semin Pediatr Neurol. 2012;19(3):101–6. doi:.https://doi.org/10.1016/j.spen.2012.02.008
  34. Boesch C, Issakainen J, Kewitz G, Kikinis R, Martin E, Boltshauser E. Magnetic resonance imaging of the brain in congenital cytomegalovirus infection. Pediatr Radiol. 1989;19(2):91–3. doi:.https://doi.org/10.1007/BF02387893
  35. Barkovich AJ, Lindan CE. Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am J Neuroradiol. 1994;15(4):703–15.
  36. Kimberlin DW, Jester P, Sanchez PJ, Ahmed A, Sood S, Woods C, et al. Six months versus six weeks of oral valganciclovir for infants with symptomatic congenital cytomegalovirus (CMV) disease with and without central nervous system (CNS) involvement: Results of a Phase III, randomized, double-blind, placebo-controlled, multinational study [abstract LB-1]. In IDWeek 2013, San Francisco, CA, October 2 to 6, 2013; 2013 [cited 2014 Jul 29]. Available from: https://idsa.confex.com/idsa/2013/webprogram/Paper43178.html
  37. Griffiths R. The Abilities of Babies. Oxford: The Test Agency; 1970.
  38. Bayley N. Bayley scales of Infant Development. 2nd edition. San Antonio, TX: Harcourt Assessment Company; 1993.
  39. Kaufman AS, Kaufman NL. Kaufman Assessment Battery for Children. Circle Pines MN: American Guidance Service; 1983.
  40. Wechsler D. Echelle de Wechsler pour la période préscolaire et primaire. 3ième édition. Paris: Editions du Centre de Psychologie Appliquée; 2002.
  41. Growth Fenton. 2013 [Internet]. [cited 2016 Apr 30]. Available from: http://www.peditools.org/fenton2013/
  42. Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics. 2002;110(4):762–7. doi:.https://doi.org/10.1542/peds.110.4.762
  43. Cannon MJ, Griffiths PD, Aston V, Rawlinson WD. Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? Rev Med Virol. 2014;24(5):291–307. doi:.https://doi.org/10.1002/rmv.1790
  44. Gunkel J, Nijman J, Verboon-Maciolek MA, Wolfs T, de Vries LS. International opinions and national surveillance suggest insufficient consensus regarding the recognition and management practices of infants with congenital cytomegalovirus infections. Acta Paediatr. 2017;106(9):1493–8. doi:.https://doi.org/10.1111/apa.13882